Global Acute Pancreatitis Market: Information by Cause (Gallstones, Alcohol and Other Causes), by Treatment & Diagnosis (Treatment [Intravenous Fluid, Analgesics, Nutritional Support, Endoscopic Retrograde Cholangiopancreatography (ERCP) and Others] and Diagnosis[Imaging Tests, Laboratory Tests]), By End User (Hospitals & Clinics and Others) and by Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2027
Market Highlights
Acute Pancreatitis Market is estimated to be valued at USD 7372.01 Million by 2025 and is expected to register a CAGR of 5.91% during the forecast period.
Acute pancreatitis is a condition where the pancreas becomes inflamed. The most common cause of acute pancreatitis is stones in the gallbladder. Acute pancreatitis is the single-most frequent gastrointestinal cause for hospital admissions in the US, with nearly 275,000 hospitalizations annually.
There are several other reasons, such as heavy alcohol consumption, ingested medicines, and others that cause acute pancreatitis. The rising prevalence of gallstones and high consumption of alcohol is driving the global acute pancreatitis market. However, stringent regulations imposed by the FDA (Food and Drug Administration) are expected to hamper the growth of this market.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1565
Segment Analysis
The Global Acute Pancreatitis Market has been segmented into Cause, Treatment & Diagnosis, and End User.
Based on the cause, the global acute pancreatitis market has been segmented into gallstones, alcohol, and others. The gallstones segment accounted for the largest market share of 49.52% in 2018 and is expected to exhibit a CAGR of 5.88% by the end of the forecast period. Rising cases of gall stones worldwide and growing older population along with hereditary predispositions are major risk factors causing gall stones, which is driving the growth of the acute pancreatitis market. For instance, according to the World Gastroenterology Organization, about 20 million people in the USA (15% of the population) had gallstones in 2016.
On the basis of treatment & diagnosis, the global acute pancreatitis market has been segregated into treatment and diagnosis. The treatment segment is further classified as intravenous fluid, nutritional support, analgesics, endoscopic retrograde cholangiopancreatography (ERCP), and others. The diagnosis segment is further classified as imaging tests and laboratory tests.
On the basis of end-user, the global acute pancreatitis market has been segmented into hospitals & clinics and others.
Regional Analysis
The Global Acute Pancreatitis Market has been segmented based on region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The increasing prevalence of gall stones and alcohol consumption among the population and the availability of advanced healthcare facilities in the US and Canada are likely to support the dominance of the Americas on this market during the forecast period. Additionally, the rising geriatric population increases the rate of prevalence of gallstones as they are more susceptible to diseases. The increasing incidence of acute pancreatitis has led to a rise in the demand for advanced and effective diagnostic tests and treatment options.
Market Players
Market Research Future (MRFR) recognizes CalciMedica, SCM Lifescience, Samsung Bioepis, GNT Pharma Co., Baxter International Inc., B. Braun Melsungen AG, General Electric Company, Medtronic, Boston Scientific Corporation, and Fresenius Kabi USA as the key players in the Global Acute Pancreatitis Market.
Key Findings of the Study:
- The Global Acute Pancreatitis Market is projected to reach over USD 7372.01 Million by 2025 at a 91% CAGR during the review period of 2019 to 2025.
- Americas accounted for the largest market share with the US being the major contributor to the growth of the market.
- By cause, the gallstones segment is projected to register the largest market share of 49.52% during the forecast period. According to a recent research study by the Dutch Pancreatitis Study Group, the most common cause of acute pancreatitis in Europe and North America is gall bladder.
- Key manufacturers are adopting geographic expansions, corporate acquisitions, and product launches as growth strategies.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/acute-pancreatitis-market-1565
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
Global Acute Pancreatitis Market: Information by Cause (Gallstones, Alcohol and Other Causes), by Treatment & Diagnosis (Treatment [Intravenous Fluid, Analgesics, Nutritional Support, Endoscopic Retrograde Cholangiopancreatography (ERCP) and Others] and Diagnosis[Imaging Tests, Laboratory Tests]), By End User (Hospitals & Clinics and Others) and by Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2027Market HighlightsAcute Pancreatitis Market is estimated to be valued at USD 7372.01 Million by 2025 and is expected to register a CAGR of 5.91% during the forecast period.Acute pancreatitis is a condition where the pancreas becomes inflamed.
The most common cause of acute pancreatitis is stones in the gallbladder.
Acute pancreatitis is the single-most frequent gastrointestinal cause for hospital admissions in the US, with nearly 275,000 hospitalizations annually.There are several other reasons, such as heavy alcohol consumption, ingested medicines, and others that cause acute pancreatitis.
However, stringent regulations imposed by the FDA (Food and Drug Administration) are expected to hamper the growth of this market.Segment AnalysisThe Global Acute Pancreatitis Market has been segmented into Cause, Treatment & Diagnosis, and End User.Based on the cause, the global acute pancreatitis market has been segmented into gallstones, alcohol, and others.
Rising cases of gall stones worldwide and growing older population along with hereditary predispositions are major risk factors causing gall stones, which is driving the growth of the acute pancreatitis market.
The treatment segment is further classified as intravenous fluid, nutritional support, analgesics, endoscopic retrograde cholangiopancreatography (ERCP), and others.
Electronic health records have gained precedence across all major healthcare organizations since being made mandatory by reputed bodies.
The digitization of patient data, as well as the pertinent recording of patient in/out data, surgical history, past payment details, frequency of visits, medication history, and progress notes, is likely to pave new avenues for the global acute care EHR market report as observed by Market Research Future (MRFR).Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/4930 Acute Care EHR Market OutlookThe global acute care EHR market is set to achieve a high valuation at a 7% CAGR from 2017 to 2023 (forecast period), according to MRFR.
According to the Center for Disease Control & Prevention (CDC), in 2015, 7 out of 10 deaths were caused by chronic diseases.Large number of hospitals, heavy patient inflow, and low number of employees are factors which can drive the market growth.
New HIPAA policies that encourage the use of software and other technology for diagnosis of patients will augur favorably for the acute care EHR market growth.But exorbitant costs of software may impede the market growth.SegmentationThe global Acute Care EHR Market Size has been segmented based on deployment, application, and end user.
By deployment, the global acute care EHR market has been segmented into On-Premises based and Web-based.By application, the global acute care EHR market has been segmented into personal care, pharmaceuticals, and others.By end user, the global acute care EHR market has been segmented into hospital, ambulatory care, and others.Acute Care EHR Market Regional AnalysisThe Middle East & Africa (MEA), the Americas, Asia Pacific (APAC), and Europe are regions taken into consideration in the compilation of the global acute care EHR market report.The Americas can dominate the global market due to the large patient base, adoption of latest technology, and large number of hospitals and ambulatory care centers.
Large healthcare expenditure and ample funding by private organizations and charities can drive the regional acute care EHR market.
